Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,143,598
  • Shares Outstanding, K 189,880
  • Annual Sales, $ 2,419 M
  • Annual Income, $ 167,650 K
  • 60-Month Beta 0.32
  • Price/Sales 6.59
  • Price/Cash Flow 46.90
  • Price/Book 3.14
Trade BMRN with:

Options Overview Details

View History
  • Implied Volatility 28.75% ( +0.17%)
  • Historical Volatility 20.51%
  • IV Percentile 58%
  • IV Rank 28.31%
  • IV High 44.83% on 02/13/24
  • IV Low 22.40% on 11/03/23
  • Put/Call Vol Ratio 0.15
  • Today's Volume 786
  • Volume Avg (30-Day) 1,349
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 48,518
  • Open Int (30-Day) 49,743

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.37
  • Number of Estimates 10
  • High Estimate 0.47
  • Low Estimate 0.23
  • Prior Year 0.34
  • Growth Rate Est. (year over year) +8.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.53 +5.58%
on 07/05/24
86.13 -1.28%
on 06/18/24
+0.47 (+0.56%)
since 06/12/24
3-Month
73.68 +15.40%
on 05/30/24
93.36 -8.93%
on 04/15/24
-7.20 (-7.81%)
since 04/12/24
52-Week
73.68 +15.40%
on 05/30/24
99.56 -14.60%
on 12/14/23
-0.22 (-0.26%)
since 07/12/23

Most Recent Stories

More News
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Plain-as-day bargains can still be found, even with the innovation-fueled Nasdaq Composite powering to a fresh all-time high.

COMP : 4.11 (+3.53%)
$NASX : 18,398.45 (+0.63%)
META : 498.87 (-2.70%)
FVRR : 23.50 (+3.39%)
BMRN : 85.02 (+1.32%)
WDC : 78.77 (+1.19%)
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Opportunistic investors can still find bargains, even with the Nasdaq Composite up 49% since the start of 2023.

COMP : 4.11 (+3.53%)
$NASX : 18,398.45 (+0.63%)
INTC : 34.49 (+2.96%)
BMRN : 85.02 (+1.32%)
S : 20.34 (+0.54%)
PYPL : 60.27 (+0.47%)
BioMarin: Q1 Earnings Snapshot

BioMarin: Q1 Earnings Snapshot

BMRN : 85.02 (+1.32%)
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Although the Nasdaq Composite is galloping to record highs, amazing deals among growth stocks can still be uncovered.

COMP : 4.11 (+3.53%)
$NASX : 18,398.45 (+0.63%)
PYPL : 60.27 (+0.47%)
FVRR : 23.50 (+3.39%)
BMRN : 85.02 (+1.32%)
GOOGL : 185.07 (-0.27%)
GOOG : 186.78 (-0.28%)
BioMarin: Q4 Earnings Snapshot

BioMarin: Q4 Earnings Snapshot

BMRN : 85.02 (+1.32%)
3 No-Brainer Stocks to Buy With $200 Right Now

A reasonably small amount of money can go a long way when it's put to work in innovative, industry-leading businesses.

NEE : 76.00 (+1.74%)
BMRN : 85.02 (+1.32%)
PM : 105.95 (+0.90%)
New Era at Elliott: Appointing Partners to Spearhead Diverse Investments

Elliott Investment Management, the renowned activist investment firm founded by billionaire Paul Singer, is enhancing its leadership with the appointment of three new partners. In a strategic move, Elliott...

CCI : 103.55 (+1.18%)
PINS : 41.29 (-1.97%)
ETSY : 60.50 (+3.76%)
PSX : 138.64 (+1.26%)
GT : 11.35 (unch)
BMRN : 85.02 (+1.32%)
STZ : 259.82 (+0.17%)
CRM : 253.97 (+1.13%)
CTXS : 103.90 (+0.04%)
4 Marvelous Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

A greater than 7% decline in the Nasdaq Composite from its record high signals that opportunistic investors can still find bargains.

COMP : 4.11 (+3.53%)
$NASX : 18,398.45 (+0.63%)
MA : 440.11 (+0.85%)
BMRN : 85.02 (+1.32%)
ETSY : 60.50 (+3.76%)
META : 498.87 (-2.70%)
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

An 11% decline in the Nasdaq Composite over the past two years is an open invitation for opportunistic growth investors to go shopping.

COMP : 4.11 (+3.53%)
$NASX : 18,398.45 (+0.63%)
NIO : 4.87 (+4.06%)
OKTA : 96.08 (+3.03%)
BMRN : 85.02 (+1.32%)
BIDU : 99.07 (-1.59%)
4 Unique Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

A 19% decline in the Nasdaq Composite over the past two years represents an ideal time for opportunistic long-term investors to go shopping for bargains.

COMP : 4.11 (+3.53%)
$NASX : 18,398.45 (+0.63%)
GOOGL : 185.07 (-0.27%)
GOOG : 186.78 (-0.28%)
FSLY : 7.44 (-0.53%)
BMRN : 85.02 (+1.32%)
ETSY : 60.50 (+3.76%)
AMZN : 194.49 (-0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 88.42
2nd Resistance Point 87.09
1st Resistance Point 86.05
Last Price 85.02
1st Support Level 83.68
2nd Support Level 82.35
3rd Support Level 81.31

See More

52-Week High 99.56
Fibonacci 61.8% 89.67
Fibonacci 50% 86.62
Last Price 85.02
Fibonacci 38.2% 83.56
52-Week Low 73.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar